Table III.
Ln(Current TCE exposure levels)(ppm) | Ln(Cumulative TCE exposure levels)(ppm. years) | |||||
---|---|---|---|---|---|---|
Parameter | Estimate | 95% CI | P-value | Estimate | 95% CI | P-value |
Urinary markers | ||||||
Ln(VEGF) [ng l−1]b | −0.01 | −0.04 to 0.01 | 0.34 | −0.02 | −0.05 to 0.009 | 0.19 |
Ln(AlphaGST) [µg l−1] | −0.003 | −0.04 to 0.03 | 0.87 | −0.0005 | −0.04 to 0.04 | 0.71 |
Ln(PiGST) [µg l−1] | −0.03 | −0.00 to 0.05 | 0.06 | −0.03 | −0.00 to 0.06 | 0.05 |
Ln(KIM-1) [ng l−1] | −0.05 | −0.03 to 0.08 | 0.0001 | −0.06 | −0.03 to 0.08 | 0.0001 |
Ln(NAG) [units l−1] | −0.006 | −0.05 to 0.04 | 0.81 | −0.01 | −0.06 to 0.04 | 0.68 |
a Adjusted for ln(creatinine), sex, current alcohol use, and BMI.
b Samples of one control and three exposed subjects were not analysed for VEGF.